Evolution of the complex transcription network controlling biofilm formation in Candida species

  1. Eugenio Mancera  Is a corresponding author
  2. Isabel Nocedal
  3. Stephen Hammel
  4. Megha Gulati
  5. Kaitlin F Mitchell
  6. David R Andes
  7. Clarissa J Nobile
  8. Geraldine Butler
  9. Alexander D Johnson
  1. Centro de Investigación y de Estudios Avanzados, Unidad Irapuato, Mexico
  2. Massachusetts Institute of Technology, United States
  3. University College Cork, Ireland
  4. Cell Press, United States
  5. Centers for Disease Control and Prevention, United States
  6. University of Wisconsin, United States
  7. University of California, Merced, United States
  8. Conway Institute, University College Dublin, Ireland
  9. University of California, San Francisco, United States

Abstract

We examine how a complex transcription network composed of seven 'master' regulators and hundreds of target genes evolved over a span of approximately 70 million years. The network controls biofilm formation in several Candida species, a group of fungi that are present in humans both as constituents of the microbiota and as opportunistic pathogens. Using a variety of approaches, we observed two major types of changes that have occurred in the biofilm network since the four extant species we examined last shared a common ancestor. Master regulator 'substitutions' occurred over relatively long evolutionary times, resulting in different species having overlapping, but different sets of master regulators of biofilm formation. Second, massive changes in the connections between the master regulators and their target genes occurred over much shorter timescales. We believe this analysis is the first detailed, empirical description of how a complex transcription network has evolved.

Data availability

ChIP-Seq and microarray gene expression data has been deposited to the NCBI Gene Expression Omnibus (GEO) repository under Superseries GSE160783

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Eugenio Mancera

    Departamento de Ingeniería Genética, Centro de Investigación y de Estudios Avanzados, Unidad Irapuato, Irapuato, Mexico
    For correspondence
    eugenio.mancera@cinvestav.mx
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0146-8732
  2. Isabel Nocedal

    Department of Biology, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4706-1113
  3. Stephen Hammel

    The School of Computer Sciences and IT, University College Cork, Cork, Ireland
    Competing interests
    No competing interests declared.
  4. Megha Gulati

    Molecular Cell, Cell Press, Cambridge, United States
    Competing interests
    No competing interests declared.
  5. Kaitlin F Mitchell

    Center for Global Health, Centers for Disease Control and Prevention, Atlanta, United States
    Competing interests
    No competing interests declared.
  6. David R Andes

    Departments of Medicine and Medical Microbiology and Immunology, University of Wisconsin, Madison, United States
    Competing interests
    No competing interests declared.
  7. Clarissa J Nobile

    Molecular and Cell Biology, University of California, Merced, Merced, United States
    Competing interests
    Clarissa J Nobile, Clarissa J. Nobile and Alexander D. Johnson are cofounders of BioSynesis, Inc., a company developing diagnostics and therapeutics for biofilm formation..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0799-6499
  8. Geraldine Butler

    School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1770-5301
  9. Alexander D Johnson

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    Alexander D Johnson, Clarissa J. Nobile and Alexander D. Johnson are cofounders of BioSynesis, Inc., a company developing diagnostics and therapeutics for biofilm formation..

Funding

Human Frontiers Science Program (LT000484/2012-L)

  • Eugenio Mancera

Pew Biomedical Schoolar Award

  • Clarissa J Nobile

Kamangar family endowed chair

  • Clarissa J Nobile

UC-MEXUS

  • Eugenio Mancera

CONACyT (CB-2016-01 282511)

  • Eugenio Mancera

Wellcome Trust Seed Award in Science (209077/Z/17/Z)

  • Eugenio Mancera

National Institute of Health (Ro1AI083311)

  • Alexander D Johnson

National Institute of Health (Ro1AI049187)

  • Alexander D Johnson

National Institute of Health (Ro1AI073289)

  • David R Andes

National Institute of Health (R35GM124594)

  • Clarissa J Nobile

National Institute of Health (R21AI125801)

  • Clarissa J Nobile

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Wisconsin, Madison (protocol MV1947).

Copyright

© 2021, Mancera et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,313
    views
  • 372
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Eugenio Mancera
  2. Isabel Nocedal
  3. Stephen Hammel
  4. Megha Gulati
  5. Kaitlin F Mitchell
  6. David R Andes
  7. Clarissa J Nobile
  8. Geraldine Butler
  9. Alexander D Johnson
(2021)
Evolution of the complex transcription network controlling biofilm formation in Candida species
eLife 10:e64682.
https://doi.org/10.7554/eLife.64682

Share this article

https://doi.org/10.7554/eLife.64682

Further reading

    1. Evolutionary Biology
    Ljiljana Mihajlovic, Bharat Ravi Iyengar ... Yolanda Schaerli
    Research Article

    Gene duplication drives evolution by providing raw material for proteins with novel functions. An influential hypothesis by Ohno (1970) posits that gene duplication helps genes tolerate new mutations and thus facilitates the evolution of new phenotypes. Competing hypotheses argue that deleterious mutations will usually inactivate gene duplicates too rapidly for Ohno’s hypothesis to work. We experimentally tested Ohno’s hypothesis by evolving one or exactly two copies of a gene encoding a fluorescent protein in Escherichia coli through several rounds of mutation and selection. We analyzed the genotypic and phenotypic evolutionary dynamics of the evolving populations through high-throughput DNA sequencing, biochemical assays, and engineering of selected variants. In support of Ohno’s hypothesis, populations carrying two gene copies displayed higher mutational robustness than those carrying a single gene copy. Consequently, the double-copy populations experienced relaxed purifying selection, evolved higher phenotypic and genetic diversity, carried more mutations and accumulated combinations of key beneficial mutations earlier. However, their phenotypic evolution was not accelerated, possibly because one gene copy rapidly became inactivated by deleterious mutations. Our work provides an experimental platform to test models of evolution by gene duplication, and it supports alternatives to Ohno’s hypothesis that point to the importance of gene dosage.

    1. Cell Biology
    2. Evolutionary Biology
    Paul Richard J Yulo, Nicolas Desprat ... Heather L Hendrickson
    Research Article

    Maintenance of rod-shape in bacterial cells depends on the actin-like protein MreB. Deletion of mreB from Pseudomonas fluorescens SBW25 results in viable spherical cells of variable volume and reduced fitness. Using a combination of time-resolved microscopy and biochemical assay of peptidoglycan synthesis, we show that reduced fitness is a consequence of perturbed cell size homeostasis that arises primarily from differential growth of daughter cells. A 1000-generation selection experiment resulted in rapid restoration of fitness with derived cells retaining spherical shape. Mutations in the peptidoglycan synthesis protein Pbp1A were identified as the main route for evolutionary rescue with genetic reconstructions demonstrating causality. Compensatory pbp1A mutations that targeted transpeptidase activity enhanced homogeneity of cell wall synthesis on lateral surfaces and restored cell size homeostasis. Mechanistic explanations require enhanced understanding of why deletion of mreB causes heterogeneity in cell wall synthesis. We conclude by presenting two testable hypotheses, one of which posits that heterogeneity stems from non-functional cell wall synthesis machinery, while the second posits that the machinery is functional, albeit stalled. Overall, our data provide support for the second hypothesis and draw attention to the importance of balance between transpeptidase and glycosyltransferase functions of peptidoglycan building enzymes for cell shape determination.